REACTOME_G_ALPHA_S_SIGNALLING_EVENTS |
Return to index |
|
|
|
|
|
Order |
Gene |
Description |
ref_hepatocyte |
HepG2 |
HepG2.C3A |
HuH.7 |
SNU475 |
THLE |
liver |
1 |
GNAS |
Guanine nucleotide-binding protein
G(s) subunit alpha isoforms XLas |
0.24[1] |
0.25[2] |
-0.07[3] |
0.34[4] |
-0.35[5] |
-1.23[6] |
2 |
GNG5 |
Guanine nucleotide-binding protein
G(I)/G(S)/G(O) subunit gamma-5 |
-1.39[7] |
-1.24[8] |
-2.08[9] |
-2.32[10] |
-2.50[11] |
-1.48[12] |
3 |
GNB1 |
Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 |
[13] |
0.82[14] |
0.82[15] |
0.36[16] |
0.78[17] |
0.65[18] |
-1.13[19] |
4 |
GNB2 |
Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 |
[20] |
-0.79[21] |
-1.06[22] |
-0.71[23] |
-0.87[24] |
-0.74[25] |
-1.50[26] |
5 |
GNG10 |
Guanine nucleotide-binding protein
G(I)/G(S)/G(O) subunit gamma-10 |
-4.89[27] |
-4.62[28] |
-4.91[29] |
-4.32[30] |
-3.42[31] |
-4.24[32] |
6 |
GNAI2 |
Guanine nucleotide-binding protein G(i) subunit alpha-2 |
[33] |
-0.12[34] |
-1.21[35] |
-1.02[36] |
-0.68[37] |
0.47[38] |
-0.09[39] |
7 |
GNG12 |
Guanine nucleotide-binding protein
G(I)/G(S)/G(O) subunit gamma-12 |
-4.94[40] |
-7.89[41] |
0.08[42] |
1.37[43] |
1.55[44] |
0.59[45] |
8 |
GNAI3 |
Guanine nucleotide-binding protein G(k) subunit alpha |
[46] |
-0.07[47] |
0.46[48] |
0.58[49] |
0.60[50] |
0.30[51] |
0.34[52] |
9 |
ADM |
ADM |
[53] |
-0.27[54] |
-0.98[55] |
-1.60[56] |
0.15[57] |
-0.27[58] |
-0.71[59] |
10 |
ARRB2 |
Beta-arrestin-2 |
[60] |
-0.02[61] |
0.34[62] |
0.32[63] |
-1.82[64] |
-0.94[65] |
-0.77[66] |
11 |
RAMP1 |
Receptor activity-modifying protein 1 |
[67] |
-4.74[68] |
-9.37[69] |
-1.81[70] |
-3.97[71] |
-4.02[72] |
0.68[73] |
12 |
GNAI1 |
Guanine nucleotide-binding protein G(i) subunit alpha-1 |
[74] |
-1.84[75] |
-2.80[76] |
-0.64[77] |
0.71[78] |
0.16[79] |
0.94[80] |
13 |
PDE8A |
High affinity cAMP-specific and
IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A |
0.15[81] |
0.73[82] |
1.08[83] |
-0.79[84] |
-0.19[85] |
1.64[86] |
14 |
CALCA |
Calcitonin |
[87] |
[88] |
[89] |
-10.63[90] |
[91] |
-9.58[92] |
-0.99[93] |
15 |
GNB5 |
Guanine nucleotide-binding protein subunit beta-5 |
[94] |
-0.09[95] |
-0.07[96] |
0.97[97] |
0.28[98] |
0.48[99] |
0.99[100] |
16 |
SRC |
Proto-oncogene tyrosine-protein kinase Src |
[101] |
2.83[102] |
2.80[103] |
1.82[104] |
1.89[105] |
1.14[106] |
-0.74[107] |
17 |
GRK6 |
G protein-coupled receptor kinase 6 |
[108] |
0.98[109] |
1.06[110] |
1.99[111] |
0.23[112] |
1.09[113] |
-0.21[114] |
18 |
PDE3B |
cGMP-inhibited 3',5'-cyclic phosphodiesterase B |
[115] |
0.26[116] |
1.20[117] |
1.47[118] |
-1.89[119] |
-2.25[120] |
2.98[121] |
19 |
ADCY9 |
Adenylate cyclase type 9 |
[122] |
2.43[123] |
1.60[124] |
2.04[125] |
0.45[126] |
0.07[127] |
2.52[128] |
20 |
ADRB2 |
Beta-2 adrenergic receptor |
[129] |
-7.71[130] |
[131] |
[132] |
-3.90[133] |
-4.45[134] |
0.31[135] |
21 |
GRK5 |
G protein-coupled receptor kinase 5 |
[136] |
1.82[137] |
2.24[138] |
0.32[139] |
-0.20[140] |
0.44[141] |
0.26[142] |
22 |
ADCY6 |
Adenylate cyclase type 6 |
[143] |
1.86[144] |
2.30[145] |
2.28[146] |
2.00[147] |
2.75[148] |
2.74[149] |
23 |
GNAZ |
Guanine nucleotide-binding protein G(z) subunit alpha |
[150] |
1.70[151] |
2.15[152] |
1.45[153] |
-2.51[154] |
-2.00[155] |
-3.21[156] |
24 |
GNG11 |
Guanine nucleotide-binding protein
G(I)/G(S)/G(O) subunit gamma-11 |
-8.37[157] |
-8.39[158] |
-7.68[159] |
1.76[160] |
3.15[161] |
2.34[162] |
25 |
ADM2 |
ADM2 |
[163] |
0.84[164] |
1.03[165] |
2.79[166] |
-2.37[167] |
-0.53[168] |
0.13[169] |
26 |
GPR39 |
G-protein coupled receptor 39 |
[170] |
-1.62[171] |
-2.35[172] |
-2.07[173] |
-2.30[174] |
-2.74[175] |
0.35[176] |
27 |
ADORA2A |
Adenosine receptor A2a |
[177] |
-0.77[178] |
-0.32[179] |
1.42[180] |
-1.11[181] |
-2.84[182] |
1.30[183] |
28 |
GPR176 |
G-protein coupled receptor 176 |
[184] |
-3.27[185] |
-4.30[186] |
0.60[187] |
2.11[188] |
3.03[189] |
-0.49[190] |
29 |
GNG7 |
Guanine nucleotide-binding protein
G(I)/G(S)/G(O) subunit gamma-7 |
1.37[191] |
1.00[192] |
1.82[193] |
-2.74[194] |
-2.04[195] |
0.13[196] |
30 |
POMC |
Pro-opiomelanocortin |
[197] |
[198] |
-8.57[199] |
[200] |
[201] |
-7.55[202] |
-2.09[203] |
31 |
RAMP3 |
Receptor activity-modifying protein 3 |
[204] |
[205] |
[206] |
[207] |
-9.62[208] |
[209] |
3.15[210] |
32 |
ADCY1 |
Adenylate cyclase type 1 |
[211] |
-1.03[212] |
-2.91[213] |
-3.10[214] |
-2.62[215] |
-2.56[216] |
5.10[217] |
33 |
RAMP2 |
Receptor activity-modifying protein 2 |
[218] |
-1.32[219] |
-1.12[220] |
1.53[221] |
-1.90[222] |
-1.87[223] |
1.18[224] |
34 |
GNG4 |
Guanine nucleotide-binding protein
G(I)/G(S)/G(O) subunit gamma-4 |
3.28[225] |
1.02[226] |
4.84[227] |
0.75[228] |
-1.29[229] |
-2.45[230] |
35 |
ARRB1 |
Beta-arrestin-1 |
[231] |
3.39[232] |
3.18[233] |
2.49[234] |
1.64[235] |
1.53[236] |
3.38[237] |
36 |
PDE7A |
High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A |
[238] |
1.80[239] |
2.38[240] |
2.88[241] |
3.27[242] |
1.99[243] |
2.30[244] |
37 |
ADCY7 |
Adenylate cyclase type 7 |
[245] |
3.32[246] |
2.92[247] |
1.90[248] |
2.80[249] |
2.35[250] |
3.03[251] |
38 |
PDE4C |
cAMP-specific 3',5'-cyclic phosphodiesterase 4C |
[252] |
2.78[253] |
2.20[254] |
0.72[255] |
-1.70[256] |
0.05[257] |
-0.76[258] |
39 |
GNB4 |
Guanine nucleotide-binding protein subunit beta-4 |
[259] |
-0.56[260] |
-0.09[261] |
0.93[262] |
2.17[263] |
4.99[264] |
4.19[265] |
40 |
GNG2 |
Guanine nucleotide-binding protein
G(I)/G(S)/G(O) subunit gamma-2 |
-6.47[266] |
-7.37[267] |
[268] |
2.61[269] |
2.16[270] |
2.88[271] |
41 |
PDE4A |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A |
[272] |
2.93[273] |
1.84[274] |
3.23[275] |
0.09[276] |
3.00[277] |
1.61[278] |
42 |
P2RY11 |
P2Y purinoceptor 11 |
[279] |
-1.28[280] |
-1.90[281] |
-1.04[282] |
-3.89[283] |
-1.53[284] |
-3.19[285] |
43 |
PDE2A |
cGMP-dependent 3',5'-cyclic phosphodiesterase |
[286] |
1.33[287] |
-4.88[288] |
-3.81[289] |
-4.09[290] |
0.30[291] |
4.97[292] |
44 |
ADORA2B |
Adenosine receptor A2b |
[293] |
3.92[294] |
3.66[295] |
1.28[296] |
2.02[297] |
2.98[298] |
-1.10[299] |
45 |
IAPP |
Islet amyloid polypeptide |
[300] |
-2.07[301] |
-1.38[302] |
-1.19[303] |
-2.42[304] |
-2.27[305] |
-1.36[306] |
46 |
PDE11A |
Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A |
[307] |
1.94[308] |
1.16[309] |
1.85[310] |
2.54[311] |
-3.11[312] |
4.52[313] |
47 |
AVP |
Vasopressin-neurophysin 2-copeptin |
[314] |
-4.25[315] |
-1.83[316] |
-2.23[317] |
[318] |
-7.99[319] |
-0.96[320] |
48 |
GPBAR1 |
G-protein coupled bile acid receptor 1 |
[321] |
-3.39[322] |
-3.71[323] |
-4.24[324] |
-3.78[325] |
-3.78[326] |
1.69[327] |
49 |
GNGT2 |
Guanine nucleotide-binding protein
G(I)/G(S)/G(O) subunit gamma-T2 |
[328] |
[329] |
[330] |
-2.57[331] |
-7.17[332] |
0.21[333] |
50 |
SCTR |
Secretin receptor |
[334] |
-1.75[335] |
0.78[336] |
1.95[337] |
-0.45[338] |
-5.11[339] |
1.35[340] |
51 |
PTGER2 |
Prostaglandin E2 receptor EP2 subtype |
[341] |
[342] |
[343] |
0.74[344] |
4.28[345] |
3.18[346] |
1.50[347] |
52 |
GNG3 |
Guanine nucleotide-binding protein
G(I)/G(S)/G(O) subunit gamma-3 |
-1.04[348] |
0.77[349] |
-1.44[350] |
-1.21[351] |
-1.45[352] |
0.02[353] |
53 |
HTR7 |
5-hydroxytryptamine receptor 7 |
[354] |
-1.89[355] |
-5.87[356] |
-5.00[357] |
-1.54[358] |
5.23[359] |
-0.03[360] |
54 |
PDE4D |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D |
[361] |
3.26[362] |
6.38[363] |
6.50[364] |
4.07[365] |
5.37[366] |
4.84[367] |
55 |
PTGER4 |
Prostaglandin E2 receptor EP4 subtype |
[368] |
-4.22[369] |
-5.84[370] |
2.95[371] |
0.39[372] |
-0.29[373] |
3.08[374] |
56 |
ADCY3 |
Adenylate cyclase type 3 |
[375] |
1.27[376] |
0.01[377] |
3.35[378] |
4.23[379] |
5.84[380] |
3.62[381] |
57 |
MC1R |
Melanocyte-stimulating hormone receptor |
[382] |
5.30[383] |
5.86[384] |
2.05[385] |
2.94[386] |
2.53[387] |
1.20[388] |
58 |
CRHR1 |
Corticotropin-releasing factor receptor 1 |
[389] |
[390] |
-5.68[391] |
-6.24[392] |
[393] |
[394] |
[395] |
59 |
PDE7B |
cAMP-specific 3',5'-cyclic phosphodiesterase 7B |
[396] |
-2.44[397] |
-1.99[398] |
-1.01[399] |
4.19[400] |
5.83[401] |
4.88[402] |
60 |
GPHA2 |
Glycoprotein hormone alpha-2 |
[403] |
2.70[404] |
5.47[405] |
-4.87[406] |
[407] |
[408] |
-2.76[409] |
61 |
GLP2R |
Glucagon-like peptide 2 receptor |
[410] |
-1.74[411] |
-3.72[412] |
[413] |
2.76[414] |
-0.64[415] |
1.36[416] |
62 |
ADCY2 |
Adenylate cyclase type 2 |
[417] |
-5.57[418] |
-3.66[419] |
-4.90[420] |
-3.24[421] |
-4.28[422] |
-4.01[423] |
63 |
CGA |
Glycoprotein hormones alpha chain |
[424] |
[425] |
[426] |
-2.54[427] |
-4.02[428] |
-5.26[429] |
-4.00[430] |
64 |
PTHLH |
Parathyroid hormone-related protein |
[431] |
1.70[432] |
1.22[433] |
-3.33[434] |
3.99[435] |
1.32[436] |
[437] |
65 |
VIPR1 |
Vasoactive intestinal polypeptide receptor 1 |
[438] |
-0.16[439] |
-0.85[440] |
-0.62[441] |
-2.91[442] |
3.32[443] |
6.79[444] |
66 |
PDE1B |
Calcium/calmodulin-dependent
3',5'-cyclic nucleotide phosphodiesterase 1B |
-3.87[445] |
-4.86[446] |
[447] |
-1.33[448] |
-2.33[449] |
3.97[450] |
67 |
GNB3 |
Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3 |
[451] |
1.40[452] |
3.63[453] |
2.95[454] |
0.50[455] |
3.29[456] |
-1.57[457] |
68 |
PDE8B |
High affinity cAMP-specific and
IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B |
0.96[458] |
1.39[459] |
1.25[460] |
1.22[461] |
0.38[462] |
4.16[463] |
69 |
CALCRL |
Calcitonin gene-related peptide type 1 receptor |
[464] |
-3.19[465] |
-2.53[466] |
-2.48[467] |
4.00[468] |
3.25[469] |
7.23[470] |
70 |
PTGIR |
Prostacyclin receptor |
[471] |
-1.19[472] |
-4.25[473] |
[474] |
-1.07[475] |
3.38[476] |
4.96[477] |
71 |
MC2R |
Adrenocorticotropic hormone receptor |
[478] |
-0.37[479] |
0.10[480] |
-0.51[481] |
-0.03[482] |
0.04[483] |
2.66[484] |
72 |
VIP |
VIP peptides |
[485] |
-1.18[486] |
-1.16[487] |
[488] |
-0.19[489] |
-2.15[490] |
1.77[491] |
73 |
GIPR |
Gastric inhibitory polypeptide receptor |
[492] |
1.23[493] |
2.11[494] |
4.02[495] |
1.67[496] |
1.34[497] |
0.35[498] |
74 |
ADRB1 |
Beta-1 adrenergic receptor |
[499] |
-4.26[500] |
[501] |
2.11[502] |
0.02[503] |
-2.94[504] |
2.27[505] |
75 |
ADCY5 |
Adenylate cyclase type 5 |
[506] |
-0.04[507] |
0.94[508] |
1.99[509] |
0.14[510] |
1.34[511] |
6.48[512] |
76 |
TSHR |
Thyrotropin receptor |
[513] |
[514] |
-0.47[515] |
-2.97[516] |
-1.25[517] |
-4.02[518] |
6.87[519] |
77 |
GPR84 |
G-protein coupled receptor 84 |
[520] |
-4.61[521] |
-3.56[522] |
-4.80[523] |
-2.90[524] |
-0.98[525] |
-0.85[526] |
78 |
ADCYAP1 |
Pituitary adenylate cyclase-activating polypeptide |
[527] |
[528] |
[529] |
0.98[530] |
2.52[531] |
1.58[532] |
-1.09[533] |
79 |
GPR83 |
Probable G-protein coupled receptor 83 |
[534] |
1.43[535] |
3.26[536] |
1.01[537] |
-0.17[538] |
0.05[539] |
2.35[540] |
80 |
DRD5 |
D(1B) dopamine receptor |
[541] |
2.00[542] |
-0.03[543] |
-1.06[544] |
-3.16[545] |
-3.18[546] |
0.57[547] |
81 |
PDE3A |
cGMP-inhibited 3',5'-cyclic phosphodiesterase A |
[548] |
1.64[549] |
3.78[550] |
8.53[551] |
3.07[552] |
4.47[553] |
6.66[554] |
82 |
PTGDR |
Prostaglandin D2 receptor |
[555] |
[556] |
[557] |
[558] |
1.26[559] |
-0.35[560] |
4.55[561] |
83 |
PTH1R |
Parathyroid hormone/parathyroid
hormone-related peptide receptor |
-0.57[562] |
[563] |
-0.45[564] |
-1.56[565] |
1.21[566] |
8.33[567] |
84 |
MC5R |
Melanocortin receptor 5 |
[568] |
[569] |
[570] |
[571] |
[572] |
-3.47[573] |
0.38[574] |
85 |
AVPR2 |
Vasopressin V2 receptor |
[575] |
-0.17[576] |
0.19[577] |
-4.12[578] |
-0.13[579] |
-3.02[580] |
2.25[581] |
86 |
PDE1A |
Calcium/calmodulin-dependent
3',5'-cyclic nucleotide phosphodiesterase 1A |
[582] |
-0.93[583] |
3.79[584] |
5.61[585] |
2.15[586] |
6.71[587] |
87 |
HRH2 |
Histamine H2 receptor |
[588] |
1.45[589] |
0.16[590] |
-2.42[591] |
1.04[592] |
-2.02[593] |
4.62[594] |
88 |
CRHR2 |
Corticotropin-releasing factor receptor 2 |
[595] |
-3.32[596] |
[597] |
-0.08[598] |
-2.61[599] |
-0.18[600] |
0.18[601] |
89 |
GPR45 |
Probable G-protein coupled receptor 45 |
[602] |
-1.84[603] |
0.07[604] |
-0.32[605] |
-0.57[606] |
-2.93[607] |
3.79[608] |
90 |
CYSLTR2 |
Cysteinyl leukotriene receptor 2 |
[609] |
[610] |
-1.61[611] |
[612] |
-2.74[613] |
-1.61[614] |
2.55[615] |
91 |
PTH2R |
Parathyroid hormone 2 receptor |
[616] |
1.24[617] |
0.07[618] |
10.25[619] |
-0.47[620] |
0.43[621] |
2.63[622] |
92 |
ADCYAP1R1 |
Pituitary adenylate cyclase-activating polypeptide type I receptor |
[623] |
-0.81[624] |
[625] |
-2.59[626] |
1.84[627] |
[628] |
5.59[629] |
93 |
ADCY4 |
Adenylate cyclase type 4 |
[630] |
-0.10[631] |
-1.19[632] |
1.47[633] |
[634] |
[635] |
8.47[636] |
94 |
VIPR2 |
Vasoactive intestinal polypeptide receptor 2 |
[637] |
-0.52[638] |
1.49[639] |
1.04[640] |
5.30[641] |
1.33[642] |
4.67[643] |
95 |
HTR4 |
5-hydroxytryptamine receptor 4 |
[644] |
-2.52[645] |
[646] |
[647] |
[648] |
-0.61[649] |
4.99[650] |
96 |
PDE10A |
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A |
[651] |
-0.89[652] |
[653] |
[654] |
1.87[655] |
8.28[656] |
7.64[657] |
97 |
CRH |
Corticoliberin |
[658] |
[659] |
[660] |
[661] |
[662] |
[663] |
[664] |
98 |
GNG8 |
Guanine nucleotide-binding protein
G(I)/G(S)/G(O) subunit gamma-8 |
[665] |
[666] |
[667] |
[668] |
[669] |
[670] |
99 |
TAAR9 |
Trace amine-associated receptor 9 |
[671] |
[672] |
[673] |
[674] |
[675] |
[676] |
[677] |
100 |
HTR6 |
5-hydroxytryptamine receptor 6 |
[678] |
[679] |
[680] |
[681] |
[682] |
[683] |
[684] |
101 |
GPR27 |
Probable G-protein coupled receptor 27 |
[685] |
[686] |
[687] |
[688] |
[689] |
[690] |
[691] |
102 |
DRD1 |
D(1A) dopamine receptor |
[692] |
[693] |
[694] |
[695] |
[696] |
[697] |
[698] |
103 |
RXFP1 |
Relaxin receptor 1 |
[699] |
[700] |
[701] |
[702] |
[703] |
[704] |
[705] |
104 |
CALCR |
Calcitonin receptor |
[706] |
[707] |
[708] |
[709] |
[710] |
[711] |
[712] |
105 |
GPHB5 |
Glycoprotein hormone beta-5 |
[713] |
[714] |
[715] |
[716] |
[717] |
[718] |
[719] |
106 |
TAAR2 |
Trace amine-associated receptor 2 |
[720] |
[721] |
[722] |
[723] |
[724] |
[725] |
[726] |
107 |
GPR20 |
G-protein coupled receptor 20 |
[727] |
[728] |
[729] |
[730] |
[731] |
[732] |
[733] |
108 |
SCT |
Secretin |
[734] |
[735] |
[736] |
[737] |
[738] |
[739] |
[740] |
109 |
TAAR6 |
Trace amine-associated receptor 6 |
[741] |
[742] |
[743] |
[744] |
[745] |
[746] |
[747] |
110 |
PTH2 |
Tuberoinfundibular peptide of 39 residues |
[748] |
[749] |
[750] |
[751] |
[752] |
[753] |
[754] |
111 |
GLP1R |
Glucagon-like peptide 1 receptor |
[755] |
[756] |
[757] |
[758] |
[759] |
[760] |
[761] |
112 |
LHB |
Lutropin subunit beta |
[762] |
[763] |
[764] |
[765] |
[766] |
[767] |
[768] |
113 |
MC3R |
Melanocortin receptor 3 |
[769] |
[770] |
[771] |
[772] |
[773] |
[774] |
[775] |
114 |
GRK3 |
Beta-adrenergic receptor kinase 2 |
[776] |
[777] |
[778] |
[779] |
[780] |
[781] |
[782] |
115 |
RLN2 |
Prorelaxin H2 |
[783] |
[784] |
[785] |
[786] |
[787] |
[788] |
[789] |
116 |
GNGT1 |
Guanine nucleotide-binding protein G(T) subunit gamma-T1 |
[790] |
[791] |
[792] |
[793] |
[794] |
[795] |
[796] |
117 |
RXFP2 |
Relaxin receptor 2 |
[797] |
[798] |
[799] |
[800] |
[801] |
[802] |
[803] |
118 |
GNG13 |
Guanine nucleotide-binding protein
G(I)/G(S)/G(O) subunit gamma-13 |
[804] |
[805] |
[806] |
[807] |
[808] |
[809] |
119 |
GHRHR |
Growth hormone-releasing hormone receptor |
[810] |
[811] |
[812] |
[813] |
[814] |
[815] |
[816] |
120 |
ADCY8 |
Adenylate cyclase type 8 |
[817] |
[818] |
[819] |
[820] |
[821] |
[822] |
[823] |
121 |
TAAR1 |
Trace amine-associated receptor 1 |
[824] |
[825] |
[826] |
[827] |
[828] |
[829] |
[830] |
122 |
GHRH |
Somatoliberin |
[831] |
[832] |
[833] |
[834] |
[835] |
[836] |
[837] |
123 |
RLN3 |
Relaxin-3 |
[838] |
[839] |
[840] |
[841] |
[842] |
[843] |
[844] |
124 |
LHCGR |
Lutropin-choriogonadotropic hormone receptor |
[845] |
[846] |
[847] |
[848] |
[849] |
[850] |
[851] |
125 |
FSHB |
Follitropin subunit beta |
[852] |
[853] |
[854] |
[855] |
[856] |
[857] |
[858] |
126 |
INSL3 |
Insulin-like 3 |
[859] |
[860] |
[861] |
[862] |
[863] |
[864] |
[865] |
127 |
ADRB3 |
Beta-3 adrenergic receptor |
[866] |
[867] |
[868] |
[869] |
[870] |
[871] |
[872] |
128 |
PTH |
Parathyroid hormone |
[873] |
[874] |
[875] |
[876] |
[877] |
[878] |
[879] |
129 |
GNAT3 |
Guanine nucleotide-binding protein G(t) subunit alpha-3 |
[880] |
[881] |
[882] |
[883] |
[884] |
[885] |
[886] |
130 |
GRK2 |
Beta-adrenergic receptor kinase 1 |
[887] |
[888] |
[889] |
[890] |
[891] |
[892] |
[893] |
131 |
GIP |
Gastric inhibitory polypeptide |
[894] |
[895] |
[896] |
[897] |
[898] |
[899] |
[900] |
132 |
TSHB |
Thyrotropin subunit beta |
[901] |
[902] |
[903] |
[904] |
[905] |
[906] |
[907] |
133 |
NPS |
Neuropeptide S |
[908] |
[909] |
[910] |
[911] |
[912] |
[913] |
[914] |
134 |
NPSR1 |
Neuropeptide S receptor |
[915] |
[916] |
[917] |
[918] |
[919] |
[920] |
[921] |
135 |
FSHR |
Follicle-stimulating hormone receptor |
[922] |
[923] |
[924] |
[925] |
[926] |
[927] |
[928] |
136 |
MC4R |
Melanocortin receptor 4 |
[929] |
[930] |
[931] |
[932] |
[933] |
[934] |
[935] |
137 |
GPR25 |
Probable G-protein coupled receptor 25 |
[936] |
[937] |
[938] |
[939] |
[940] |
[941] |
[942] |
138 |
GPR150 |
Probable G-protein coupled receptor 150 |
[943] |
[944] |
[945] |
[946] |
[947] |
[948] |
[949] |
139 |
GCG |
Glucagon |
[950] |
[951] |
[952] |
[953] |
[954] |
[955] |
[956] |
140 |
TAAR5 |
Trace amine-associated receptor 5 |
[957] |
[958] |
[959] |
[960] |
[961] |
[962] |
[963] |
141 |
GPR15 |
G-protein coupled receptor 15 |
[964] |
[965] |
[966] |
[967] |
[968] |
[969] |
[970] |
142 |
GPR32 |
Probable G-protein coupled receptor 32 |
[971] |
[972] |
[973] |
[974] |
[975] |
[976] |
[977] |
143 |
TAAR8 |
Trace amine-associated receptor 8 |
[978] |
[979] |
[980] |
[981] |
[982] |
[983] |
[984] |
144 |
CALCB |
Calcitonin gene-related peptide 2 |
[985] |
[986] |
[987] |
[988] |
[989] |
[990] |
[991] |
|
|
|
|
|
|
|
|
|
|